Skip to main content
Erschienen in: Cancer Causes & Control 1/2013

01.01.2013 | Original paper

The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans

verfasst von: Jonathan N. Hofmann, Kendra Schwartz, Wong-Ho Chow, Julie J. Ruterbusch, Brian M. Shuch, Sara Karami, Nathaniel Rothman, Sholom Wacholder, Barry I. Graubard, Joanne S. Colt, Mark P. Purdue

Erschienen in: Cancer Causes & Control | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In the United States, renal cell carcinoma (RCC) incidence is higher among blacks than among whites. Risk of RCC is elevated among end-stage renal disease patients, although no studies have looked at differences by race in the relationship between chronic renal failure and RCC.

Methods

We investigated RCC risk in relation to chronic renal failure in a population-based case–control study of blacks and whites in Chicago and Detroit. Data, including information on kidney disease, were collected from interviews with 1,217 RCC cases (361 blacks, 856 whites) and 1,235 controls (523 blacks, 712 whites). Odds ratios (OR) and 95 % confidence intervals (CI) were estimated using unconditional logistic regression.

Results

Risk of RCC was increased in relation to chronic renal failure (OR 4.7, 95 % CI 2.2–10.1) and dialysis (OR 18.0, 95 % CI 3.6–91). The association remained after defining exposure as those who had chronic renal failure ≥10 years prior to RCC diagnosis. Chronic renal failure was more strongly associated with RCC among blacks than among whites (OR 8.7, 95 % CI 3.3–22.9 and 2.0, 0.7–5.6, respectively; p interaction = 0.03) and among those without a history of diabetes relative to diabetic subjects (OR 8.3, 95 % CI 3.1–22.7 and 1.9, 0.6–5.9, respectively; p interaction = 0.03).

Conclusions

These results suggest that chronic renal failure is a strong risk factor for RCC, particularly among black and non-diabetic subjects. Our findings of differences in risk estimates by race, to our knowledge the first such report, require replication.
Literatur
1.
Zurück zum Zitat Chow WH, Dong LM, Devesa SS (2010) Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7:245–257PubMedCrossRef Chow WH, Dong LM, Devesa SS (2010) Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7:245–257PubMedCrossRef
2.
Zurück zum Zitat Chow WH, Devesa SS (2008) Contemporary epidemiology of renal cell cancer. Cancer J 14:288–301PubMedCrossRef Chow WH, Devesa SS (2008) Contemporary epidemiology of renal cell cancer. Cancer J 14:288–301PubMedCrossRef
3.
Zurück zum Zitat Engels EA, Pfeiffer RM, Fraumeni JF, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL et al (2011) Spectrum of cancer risk among US solid organ transplant recipients. JAMA 306:1891–1901PubMedCrossRef Engels EA, Pfeiffer RM, Fraumeni JF, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL et al (2011) Spectrum of cancer risk among US solid organ transplant recipients. JAMA 306:1891–1901PubMedCrossRef
4.
Zurück zum Zitat Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354:93–99PubMedCrossRef Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354:93–99PubMedCrossRef
5.
Zurück zum Zitat Stewart JH, Buccianti G, Agodoa L, Gellert R, McCredie MR, Lowenfels AB, Disney AP, Wolfe RA, Boyle P, Maisonneuve P (2003) Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14:197–207PubMedCrossRef Stewart JH, Buccianti G, Agodoa L, Gellert R, McCredie MR, Lowenfels AB, Disney AP, Wolfe RA, Boyle P, Maisonneuve P (2003) Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14:197–207PubMedCrossRef
6.
Zurück zum Zitat Stewart JH, Vajdic CM, van Leeuwen MT, Amin J, Webster AC, Chapman JR, McDonald SP, Grulich AE, McCredie MR (2009) The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant 24:3225–3231PubMedCrossRef Stewart JH, Vajdic CM, van Leeuwen MT, Amin J, Webster AC, Chapman JR, McDonald SP, Grulich AE, McCredie MR (2009) The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant 24:3225–3231PubMedCrossRef
7.
Zurück zum Zitat Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE (2006) Cancer incidence before and after kidney transplantation. JAMA 296:2823–2831PubMedCrossRef Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE (2006) Cancer incidence before and after kidney transplantation. JAMA 296:2823–2831PubMedCrossRef
8.
Zurück zum Zitat United States Renal Data System (2011) USRDS 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda United States Renal Data System (2011) USRDS 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda
9.
Zurück zum Zitat Martins D, Tareen N, Norris KC (2002) The epidemiology of end-stage renal disease among African Americans. Am J Med Sci 323:65–71PubMedCrossRef Martins D, Tareen N, Norris KC (2002) The epidemiology of end-stage renal disease among African Americans. Am J Med Sci 323:65–71PubMedCrossRef
10.
Zurück zum Zitat Colt JS, Schwartz K, Graubard BI, Davis F, Ruterbusch J, Digaetano R, Purdue M, Rothman N, Wacholder S, Chow WH (2011) Hypertension and risk of renal cell carcinoma among white and black Americans. Epidemiology 22:797–804PubMed Colt JS, Schwartz K, Graubard BI, Davis F, Ruterbusch J, Digaetano R, Purdue M, Rothman N, Wacholder S, Chow WH (2011) Hypertension and risk of renal cell carcinoma among white and black Americans. Epidemiology 22:797–804PubMed
11.
Zurück zum Zitat Rust KF, Rao JN (1996) Variance estimation for complex surveys using replication techniques. Stat Methods Med Res 5:283–310PubMedCrossRef Rust KF, Rao JN (1996) Variance estimation for complex surveys using replication techniques. Stat Methods Med Res 5:283–310PubMedCrossRef
12.
Zurück zum Zitat McClellan W, Tuttle E, Issa A (1988) Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis 12:285–290PubMed McClellan W, Tuttle E, Issa A (1988) Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis 12:285–290PubMed
13.
Zurück zum Zitat Klein JB, Nguyen CT, Saffore L, Modlin C III, Modlin CS Jr (2010) Racial disparities in urologic health care. J Natl Med Assoc 102:108–117PubMed Klein JB, Nguyen CT, Saffore L, Modlin C III, Modlin CS Jr (2010) Racial disparities in urologic health care. J Natl Med Assoc 102:108–117PubMed
14.
Zurück zum Zitat Weng FL, Joffe MM, Feldman HI, Mange KC (2005) Rates of completion of the medical evaluation for renal transplantation. Am J Kidney Dis 46:734–745PubMedCrossRef Weng FL, Joffe MM, Feldman HI, Mange KC (2005) Rates of completion of the medical evaluation for renal transplantation. Am J Kidney Dis 46:734–745PubMedCrossRef
15.
Zurück zum Zitat Lipworth L, Tarone RE, McLaughlin JK (2011) Renal cell cancer among African Americans: an epidemiologic review. BMC Cancer 11:133PubMedCrossRef Lipworth L, Tarone RE, McLaughlin JK (2011) Renal cell cancer among African Americans: an epidemiologic review. BMC Cancer 11:133PubMedCrossRef
16.
Zurück zum Zitat Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ et al (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329:841–845PubMedCrossRef Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ et al (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329:841–845PubMedCrossRef
17.
Zurück zum Zitat Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL et al (2011) APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 22:2129–2137PubMedCrossRef Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL et al (2011) APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 22:2129–2137PubMedCrossRef
18.
Zurück zum Zitat Papeta N, Kiryluk K, Patel A, Sterken R, Kacak N, Snyder HJ, Imus PH, Mhatre AN, Lawani AK, Julian BA, Wyatt RJ, Novak J et al (2011) APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J Am Soc Nephrol 22:1991–1996PubMedCrossRef Papeta N, Kiryluk K, Patel A, Sterken R, Kacak N, Snyder HJ, Imus PH, Mhatre AN, Lawani AK, Julian BA, Wyatt RJ, Novak J et al (2011) APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J Am Soc Nephrol 22:1991–1996PubMedCrossRef
19.
Zurück zum Zitat Fung MM, Salem RM, Lipkowitz MS, Bhatnagar V, Pandey B, Schork NJ, O’Connor DT (2011) Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American study of kidney disease and hypertension (AASK) trial and veterans affairs hypertension cohort (VAHC). Nephrol Dial Transplant 27:197–205PubMedCrossRef Fung MM, Salem RM, Lipkowitz MS, Bhatnagar V, Pandey B, Schork NJ, O’Connor DT (2011) Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American study of kidney disease and hypertension (AASK) trial and veterans affairs hypertension cohort (VAHC). Nephrol Dial Transplant 27:197–205PubMedCrossRef
20.
Zurück zum Zitat Heidland A, Bahner U, Vamvakas S (2000) Incidence and spectrum of dialysis-associated cancer in three continents. Am J Kidney Dis 35:347–351; discussion 52–53 Heidland A, Bahner U, Vamvakas S (2000) Incidence and spectrum of dialysis-associated cancer in three continents. Am J Kidney Dis 35:347–351; discussion 52–53
21.
Zurück zum Zitat Guba M, Graeb C, Jauch KW, Geissler EK (2004) Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation 77:1777–1782PubMedCrossRef Guba M, Graeb C, Jauch KW, Geissler EK (2004) Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation 77:1777–1782PubMedCrossRef
22.
Zurück zum Zitat Gutierrez-Dalmau A, Campistol JM (2007) Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs 67:1167–1198PubMedCrossRef Gutierrez-Dalmau A, Campistol JM (2007) Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs 67:1167–1198PubMedCrossRef
23.
Zurück zum Zitat Centers for Disease Control and Prevention (2007) Prevalence of chronic kidney disease and associated risk factors—United States, 1999–2004. MMWR Morb Mortal Wkly Rep 56:161–165 Centers for Disease Control and Prevention (2007) Prevalence of chronic kidney disease and associated risk factors—United States, 1999–2004. MMWR Morb Mortal Wkly Rep 56:161–165
Metadaten
Titel
The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans
verfasst von
Jonathan N. Hofmann
Kendra Schwartz
Wong-Ho Chow
Julie J. Ruterbusch
Brian M. Shuch
Sara Karami
Nathaniel Rothman
Sholom Wacholder
Barry I. Graubard
Joanne S. Colt
Mark P. Purdue
Publikationsdatum
01.01.2013
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 1/2013
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0102-z

Weitere Artikel der Ausgabe 1/2013

Cancer Causes & Control 1/2013 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.